Your browser doesn't support javascript.
loading
Serum level of soluble urokinase plasminogen activator receptor (suPAR) as a disease severity marker of myasthenia gravis: a pilot study.
Uzawa, A; Kojima, Y; Ozawa, Y; Yasuda, M; Onishi, Y; Akamine, H; Kawaguchi, N; Himuro, K; Kuwabara, S.
Afiliação
  • Uzawa A; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Kojima Y; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Ozawa Y; Department of Neurology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Yasuda M; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Onishi Y; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Akamine H; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Kawaguchi N; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Himuro K; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Kuwabara S; Department of Neurology, Dowa Institute of Clinical Neuroscience, Neurology Clinic Chiba, Chiba, Japan.
Clin Exp Immunol ; 202(3): 321-324, 2020 12.
Article em En | MEDLINE | ID: mdl-32706905
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Índice de Gravidade de Doença / Receptores de Ativador de Plasminogênio Tipo Uroquinase / Miastenia Gravis Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Exp Immunol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Índice de Gravidade de Doença / Receptores de Ativador de Plasminogênio Tipo Uroquinase / Miastenia Gravis Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Exp Immunol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão